Lv3
380 积分 2024-07-07 加入
p21‐activated kinase 4 inhibition protects against liver ischemia/reperfusion injury: Role of nuclear factor erythroid 2‐related factor 2 phosphorylation
16天前
已完结
Structure-guided discovery of 6-aminopyridine derivatives for group II PAK4 inhibition
17天前
已完结
Design, synthesis and biological evaluation of novel benzimidazole-derived p21-activited kinase 4 (PAK4) inhibitors bearing a 4-(4-methylpiperazin-1-yl)phenyl scaffold as potential antitumor agents
17天前
已完结
Synthesis and biological evaluation of 7H-pyrrolo [2,3-d] pyrimidine derivatives as potential p21-activated kinase 4 (PAK4) inhibitors
17天前
已完结
Design, synthesis and anticancer activity evaluation of 4-(3-1H-indazolyl)amino quinazoline derivatives as PAK4 inhibitors
17天前
已完结
PAK4 in cancer development: Emerging player and therapeutic opportunities
17天前
已完结
Discovery of 2,4‐diaminopyrimidine derivatives targeting p21‐activated kinase 4: Biological evaluation and docking studies
26天前
已完结
Drug discovery targeting p21-activated kinase 4 (PAK4): a patent review
26天前
已完结
Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors
1个月前
已完结
Design, Synthesis, and Biological Evaluation of Selective PAK4 Degrader for the Treatment of Lung Tumor Metastasis
1个月前
已完结
皖公网安备34019202002308
